Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity
NCT00546182 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2007-10-18
Summary
We hypothesized simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients.
Conditions
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Principal Investigators
-
Kwang K Koh, MD,PhD · Gachon University Gil Medical Center
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)
NCT00551876 ·Status: COMPLETED ·Phase: PHASE3
-
A Drug Interaction Study Between Simvastatin and GSK376501
NCT00605449 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Simvastatin on Apolipoprotein B-100 (apoB-100) Secretion
NCT00905541 ·Status: COMPLETED ·Phase: NA
-
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
NCT03874260 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
NCT00566267 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
NCT00487591 ·Status: COMPLETED
-
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
NCT05614765 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
NCT00141141 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
NCT02205606 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
NCT04652349 ·Status: COMPLETED ·Phase: PHASE3
-
Differential Metabolic Effects of Fenofibrate and Fatty Acid
NCT01003847 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
NCT00256178 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
NCT01674712 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
NCT02955368 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of AD-218
NCT05400317 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia
NCT01081548 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements
NCT00365742 ·Status: COMPLETED ·Phase: NA
-
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia
NCT04554953 ·Status: COMPLETED
-
A Drug Interaction Study of Simvastatin and Albiglutide
NCT01147692 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
NCT00423579 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156 ·Status: COMPLETED ·Phase: PHASE2
-
Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
NCT02015988 ·Status: UNKNOWN ·Phase: PHASE4
-
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
NCT01544309 ·Status: COMPLETED ·Phase: NA
-
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
NCT03434613 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A
NCT05131997 ·Status: COMPLETED ·Phase: PHASE3